A phase III randomized trial of the safety and antiretroviral effects of zidovudine/lamivudine/abacavir versus zidovudine/lamivudine/lopinavir/ritonavir in the prevention of perinatal transmission of HIV.

Trial Profile

A phase III randomized trial of the safety and antiretroviral effects of zidovudine/lamivudine/abacavir versus zidovudine/lamivudine/lopinavir/ritonavir in the prevention of perinatal transmission of HIV.

Completed
Phase of Trial: Phase III

Latest Information Update: 31 May 2013

At a glance

  • Drugs Lamivudine/zidovudine (Primary) ; Lamivudine/zidovudine/abacavir (Primary) ; Lopinavir/ritonavir (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Apr 2012 Actual patient number is 19 as reported by ClinicalTrials.gov.
    • 20 Apr 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top